May 2008
691
1
cmꢁ1: 1760. H-NMR (DMSO-d6) d: 1.35 (9H, s), 2.28 (3H, s), 3.00—3.10
(2H, m), 3.68 (2H, s), 4.36—4.38 (1H, m), 6.97 (2H, d, Jꢂ8.4 Hz), 7.11
(2H, d, Jꢂ7.9 Hz), 7.23—7.35 (5H, m), 7.42 (2H, d, Jꢂ8.4 Hz), 7.48 (2H, d,
Jꢂ7.9 Hz), 7.58 (1H, d, Jꢂ7.2 Hz), 8.60 (2H, s), 9.08 (2H, s). 13C-NMR
(DMSO-d6, 100 MHz) d: 20.93, 28.25, 36.43, 37.36, 55.66, 115.68,
122.01,125.64, 126.80, 128.33, 128.48, 129.40, 130.13, 131.75, 137.29,
138.20, 145.22, 149.95, 155.74, 168.92, 171.16. [a]D25 ꢁ8.5° (cꢂ1.0,
MeOH). FAB-MS m/z: 570 (MꢃꢃH).
8) Spencer J. R., Antonenko V. V., Delaet N. G. J., Goodman N., J. Pep-
tide Protein Res., 40, 282—293 (1992).
9) Akaji K., Kuriyama N., Kiso T., Tetrahedron Lett., 35, 3315—3318
(1994).
10) Tsuzuki H., Oka T., Morihara K., J. Biochem. (Tokyo), 88, 669—675
(1980).
11) Nakatsuka T., Sasaki T., Kaiser E. T., J. Am. Chem. Soc., 109, 3808—
3810 (1987).
12) Wong C.-H., Science, 244, 1145—1152 (1989).
13) Schellenberger V., Jakubke H.-D., Angew. Chem. Int. Ed. Engl., 30,
1434—1449 (1991).
14) Bordusa F., Chem. Rev., 102, 4817—4867 (2002).
15) Kumar D., Bhalla T. C., Appl. Microbiol. Biotechnol., 68, 726—736
(2005).
16) Tanizawa K., Kasaba Y., Kanaoka Y., J. Am. Chem. Soc., 99, 4485—
4488 (1977).
17) Nakano M., Tanizawa K., Nozawa M., Kanaoka Y., Chem. Pharm.
Bull., 28, 2212—2216 (1980).
N-(tert-Butoxycarbonyl)-D-phenylalanine p-(Amidinomethyl)phenyl Ester
p-Toluenesulfonic Acid Salt (1h): A colourless amorphous powder. IR
(KBr) cmꢁ1: 1761. 1H-NMR (DMSO-d6) d: 1.30 (9H, s), 2.22 (3H, s),
2.94—3.10 (2H, m), 3.62 (2H, s), 4.28—4.33 (1H, m), 6.91 (2H, d,
Jꢂ8.4 Hz), 7.06 (2H, d, Jꢂ37.9 Hz), 7.27—7.26 (5H, m), 7.36 (2H, d,
Jꢂ8.4 Hz), 7.43 (2H, d, Jꢂ7.9 Hz), 7.51 (1H, d, Jꢂ7.2 Hz), 8.54 (2H, s),
9.04 (2H, s). 13C-NMR (DMSO-d6, 100 MHz) d: 20.93, 28.26, 36.44, 37.34,
55.66, 115.68, 122.00, 125.64, 126.81, 128.34, 128.48, 129.40, 130.14,
131.77, 137.29, 138.25, 145.15, 149.97, 155.72, 168.97, 171.20. [a]D25
ꢃ7.8° (cꢂ1.0, MeOH). FAB-MS m/z: 570 (MꢃꢃH).
18) Nozawa M., Tanizawa K., Kanaoka Y., J. Pharmacobio-Dyn., 3, 213—
219 (1980).
19) Itoh K., Sekizaki H., Toyota E., Fujiwara N., Tanizawa K., Bioorg.
Chem., 24, 59—68 (1996).
20) Sekizaki H., Itoh K., Toyota E., Tanizawa K., Chem. Pharm. Bull., 44,
1585—1587 (1996).
21) Sekizaki H., Itoh K., Toyota E., Tanizawa K., Tetraherdon Lett., 38,
1777—1780 (1997).
22) Sekizaki H., Itoh K., Toyota E., Tanizawa K., Chem. Pharm. Bull., 46,
846—849 (1998).
23) Sekizaki H., Itoh K., Toyota E., Tanizawa K., Amino Acids, 17, 285—
291 (1999).
24) Sekizaki H., Itoh K., Toyota E., Tanizawa K., Chem. Pharm. Bull., 47,
444—447 (1999).
Trypsin-Catalyzed Peptide Coupling Reaction A solution of 50 ml of
acyl donor (10 mM solution of inverse substrates in DMSO), 50 ml of acyl ac-
ceptor (200 mM solution of L-Ala-pNA in DMSO), 240 ml of 50 mM MOPS
buffer (containing 20 mM of CaCl2, pH 8.0) and 150 ml of DMSO were
mixed. To this mixture, 10 ml of trypsin solution (1 mM solution in 1 mM
HCl) was added and incubated at 25 °C. The progress of the coupling reac-
tion was monitored by HPLC under the following conditions: Shim-pack
CLC-ODS (M) (column i.d. 4.6ꢄ250 mm), isocratic elution at 1 ml/min,
0.1% aqueous trifluoroacetic acid/acetonitrile. An aliquot of the reaction
mixture was injected and the eluate was monitored at 310 nm (chromophore
due to the p-nitroanilide moiety). Peak identification was made by correlat-
ing the retention time with that of authentic samples which were chemically
synthesized.34—36) Observed peak areas were used for the estimation of sam-
ple concentration.
25) Sekizaki H., Itoh K., Toyota E., Tanizawa K., Chem. Pharm. Bull., 47,
104—110 (1999).
26) Sekizaki H., Murakami M., Itoh K., Toyota E., Tanizawa K., J. Mol.
Catal. B: Enzym., 11, 23—28 (2000).
27) Sekizaki H., Itoh K., Toyota E., Tanizawa K., Amino Acids, 21, 175—
184 (2001).
Acknowledgments This work was supported in part by a Grant-in-Aid
for High Technology Research Program from the Ministry of Education,
Culture, Sports, Science, and Technology of Japan, and by a grant from the
Japan Private School Promotion Foundation.
28) Sekizaki H., Itoh K., Toyota E., Tanizawa K., J. Peptide Sci., 8, 521—
528 (2002).
29) Sekizaki H., Itoh K., Shibuya A., Toyota E., Tanizawa K., Chem.
Pharm. Bull., 55, 1514—1517 (2007).
30) West J. B., Wong C.-H., J. Org. Chem., 51, 2728—2735 (1986).
31) Gutfreund H., Trans. Faraday Soc., 51, 441—446 (1955).
32) Yoshida N., Sasaki A., Inoue H., FEBS Lett., 15, 129—132 (1971).
33) Yokosawa H., Hanba Y., Ishii S., J. Biochem. (Tokyo), 79, 757—763
(1976).
34) Bieth J., Weremath C. G., Biochem. Biophys. Res. Commun., 53,
383—390 (1970).
35) Kawai M., Nagai U., Bull. Chem. Soc. Jpn., 55, 1327—1328 (1982).
36) Okada Y., Tsuda Y., Hirata A., Nagamatsu Y., Okamoto U., Chem.
Pharm. Bull., 30, 2212—2216 (1982).
References
1) Pandey R. C., Meng H., Cook J. C., Jr., Rinehart K. L., Jr., J. Am.
Chem. Soc., 99, 5203—5205 (1977).
2) Pandey R. C., Cook J. C., Jr., Rinehart K. L., Jr., J. Am. Chem. Soc.,
99, 5205—5206 (1977).
3) Bodo B., Rebuffat S., E. I. Hajji M., Davoust D., J. Am. Chem. Soc.,
107, 6011—6017 (1985).
4) Jost M., Greie J.-C., Stemmer N., Wilking S. D., Altendorf K., Sewald
N., Angew. Chem. Int. Ed. Engl., 41, 4267—4269 (2002).
5) Marshall G. R., Hodgkin E. E., Langs D. A., Smith G. D., Zabrocki J.,
Leplawy M. T., Proc. Natl. Acad. Sci. U.S.A., 87, 487—491 (1990).
6) Karle I. L., Balaram P., Biochemistry, 29, 6747—6756 (1990).
7) Frerot E., Coste J., Pantaloni A., Dufour M.-N., Jouin P., Tetrahedron,
47, 259—270 (1991).